# Progress Note 05 — Annual Wellness Visit, Subsequent

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Satchel Paige (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML047-SYN
- Date: 2026-10-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Delphine Whitaker-Osei, MD
- Calendar frame: modern shifted

- Visit type: Annual Wellness Visit, Subsequent
- Services: HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Subsequent annual wellness visit, two weeks after an exacerbation. **S**

## History of present illness

Mr. Paige, 73, comes for his subsequent annual wellness visit two weeks after a moderate COPD exacerbation; his last wellness visit was a year ago at his previous clinic. He finished the prednisone and doxycycline ten days ago and is back to his usual breathing, uses albuterol about once a day, and returned to pulmonary rehabilitation last week. He takes his umeclidinium-vilanterol every morning and atorvastatin every evening without muscle aches. He completed the health risk assessment beforehand. He wants all his vaccines today so that, in his words, the next cold does not knock him down. **S**

| Element | Detail |
|---|---|
| Visit | Subsequent annual wellness visit, age 73 |
| Active conditions | COPD, GOLD 2, group B, recovered from a moderate exacerbation; hyperlipidemia on atorvastatin; former smoker |
| Medicines | Umeclidinium-vilanterol daily; albuterol as needed; atorvastatin 20 mg |
| Mood and cognition | PHQ-2 0; Mini-Cog 5 |

## Health risk assessment

Completed by the patient on paper in the waiting room and reviewed with him by Dr. Whitaker-Osei. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Fair to good; better since rehabilitation |
| Psychosocial | Lives with his wife; a large family nearby; active in his church; speaks at schools |
| Alcohol | A beer on a holiday; AUDIT-C 1 at intake |
| Tobacco | Former smoker, about 30 pack-years, stopped eleven years ago; no secondhand smoke at home |
| Physical activity | Pulmonary rehabilitation twice a week and walks on other days |
| Nutrition | Regular meals; weight steady |
| Sleep | Seven hours on two pillows by habit; no snoring reported |
| Safety at home | Smoke and carbon monoxide alarms; no firearms at home; gas stove used with the window open |
| Falls | No falls |
| Activities of daily living | Independent |
| Hearing and vision | Reading glasses; hearing good |
| Oral health | Dentures; dental visit this year |
| Cost and access | The maintenance inhaler is covered through his drug plan with a low copayment; rides to rehabilitation from a church volunteer |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight loss or night sweats |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | Cold resolved |
| Respiratory | Positive | Usual breathlessness after a block; a little clear morning sputum; no wheeze |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Gastrointestinal | Negative | No indigestion or change in bowel habit |
| Genitourinary | Negative | No hesitancy or poor stream on the inhaler |
| Musculoskeletal | Negative | No muscle aches on atorvastatin; old shoulder and arm stiffness only |
| Integumentary | Negative | No rashes |
| Neurological | Negative | No numbness, weakness or memory trouble |
| Psychiatric | Negative | Mood good; PHQ-2 0 |

11 systems reviewed. **S**

## Current medications

- Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessness **S**
- Umeclidinium 62.5 micrograms with vilanterol 25 micrograms dry powder inhaler (a LAMA with a LABA), one inhalation once a day **S**
- Atorvastatin 20 mg tablet once a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/76 mmHg; pulse 76 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 95% on room air; weight 83 kg; BMI 22.8 kg/m². All vital signs are synthetic.

PHQ-2: 0; Mini-Cog: 5. All results are synthetic.

## Immunizations given today

- Influenza vaccine, high-dose, this season **S**
- Respiratory syncytial virus vaccine, single dose **S**
- COVID-19 mRNA vaccine, this season's formula **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well; weight 83.0 kg, BMI 22.8; blood pressure 128/76; pulse 76; oxygen saturation 95 percent on room air |
| Ears, nose, mouth, and throat | Throat normal; dentures fit well |
| Neck | No nodes; no raised jugular venous pressure |
| Respiratory | Reduced breath sounds at the bases; no wheeze or crackles |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Abdomen | Soft; no pulsatile mass |
| Musculoskeletal | Timed Up and Go 9 seconds |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Subsequent annual wellness visit completed**. Health risk assessment reviewed and the prevention plan updated. Fully recovered from the exacerbation. As a man of 65 to 75 who has smoked, he is due for one-time ultrasound screening for an abdominal aortic aneurysm. **S**
   - High-dose influenza, RSV and COVID-19 vaccines and the first recombinant zoster dose today; second zoster dose in two to six months.
   - Abdominal aortic ultrasound ordered.
   - Hepatitis C and hepatitis B screening drawn today.
   - Next wellness visit in one year.
2. **COPD exacerbation** (J44.1). Resolved; back to his usual breathing. **S**
   - Group and treatment review at the fifteen-week visit.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 128/76 mmHg |
| Lipid management | Up to date | LDL 86 mg/dL on atorvastatin 20 mg four weeks ago |
| Diabetes screening | Up to date | HbA1c 5.6% at intake |
| Colorectal cancer screening | Up to date | Colonoscopy five years ago without polyps, reported by his previous clinic; further screening after 75 by shared decision |
| Lung cancer screening | Up to date | Low-dose CT nine weeks ago, Lung-RADS 2; next in one year |
| Abdominal aortic aneurysm screening | Ordered | One-time ultrasound for men 65 to 75 who have ever smoked |
| Prostate cancer screening | Not indicated | PSA screening is not recommended at 70 and older |
| Hepatitis C screening | Ordered | Once for adults; drawn today |
| Hepatitis B screening | Ordered | Triple panel once for all adults; drawn today |
| Osteoporosis screening | Not indicated | Evidence insufficient for screening men; one five-day steroid course does not change this; revisit if steroid courses recur |
| Depression screening | Completed today | PHQ-2 0 |
| Cognitive assessment | Completed today | Mini-Cog 5, normal |
| Unhealthy alcohol use | Up to date | AUDIT-C 1 at intake |
| Tobacco use | Completed today | Former smoker; remains smoke-free |
| Falls risk | Completed today | No falls; Timed Up and Go 9 seconds |
| Influenza vaccine | Completed today | High-dose vaccine today |
| RSV vaccine | Completed today | Single dose today, for an adult 50 to 74 with chronic lung disease |
| COVID-19 vaccine | Completed today | This season's vaccine today after discussion |
| Zoster vaccine | Completed today | First recombinant dose today; second in two to six months |
| Pneumococcal vaccine | Up to date | PCV20 at intake; no further dose needed |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap at intake |

## Advance care planning

Voluntary advance care planning discussion of about 25 minutes, with his consent. He named a health care agent and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying at home in Kansas City, being with the people he loves, and still being able to talk with young players. If his lungs failed in a flare that could recover, he would accept a short trial of a breathing machine in intensive care, but not long-term life support if there were little chance of returning home. He will review these wishes with his family, and the plan will be revisited yearly or after any hospital stay. **S**

## Guideline basis

- Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report (2025), Global Initiative for Chronic Obstructive Lung Disease
- Lung Cancer: Screening (2021), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- Medicare Wellness Visits (Medicare Learning Network) (2026), Centers for Medicare & Medicaid Services
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Abdominal Aortic Aneurysm: Screening (2019), U.S. Preventive Services Task Force
- Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 (2023), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)

## Follow-up

- Fifteen-week review in three weeks. Aortic ultrasound and hepatitis results by then. Second zoster dose in two to six months. Next wellness visit in one year. **S**
- Next scheduled visit 2026-10-27: fifteen-week review after an exacerbation and pulmonary rehabilitation: symptoms, exacerbation history, GOLD group, oxygen, the action plan and the plan ahead. **S**
